Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ALOSYN EYE DROPS - HSA Drug Approval Details

Approvals/HSA/ALOSYN EYE DROPS

Approved

THERAPEUTIC

ALOSYN EYE DROPS

ASHFORD LABORATORIES LTD.🇸🇬 Health Sciences Authority

Approval Date: Jan 24, 2008
Approval ID: de43ba2b36e807fe
Company: ASHFORD LABORATORIES LTD.
Type: Therapeutic

Approval Details

Approval Id: de43ba2b36e807fe
Drug Name: ALOSYN EYE DROPS
Product Name: ALOSYN EYE DROPS
Approval Number: SIN13400P
Approval Date: 2008-01-24
Registrant: PETER CHIA MARKETING PTE LTD
Drug Type: Therapeutic
Forensic Classification: General Sale List
Dosage Form: SOLUTION, STERILE
Route Of Administration: OPHTHALMIC
Pharma Manufacturer Name: PETER CHIA MARKETING PTE. LTD.
Company Detail Path: /organization/peter-chia-marketing-pte-ltd

Active Ingredients

TETRAHYDROZOLINE HYDROCHLORIDE

0.40MG/ML

ANTAZOLINE HYDROCHLORIDE

0.50MG/ML

ANTAZOLINE HYDROCHLORIDE

0.50MG/ML

TETRAHYDROZOLINE HYDROCHLORIDE

0.40MG/ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 24, 2008

Approval ID

de43ba2b36e807fe

Type

Therapeutic

Back to HSA Approvals